The new business will operate under Arrow Pharma and sell 140 generic drugs. The transaction will be financed by internal accruals and debt financing. The acquisition will be EPS accretive immediately.
first published: May 21, 2015 01:02 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

